Dieter A. Enkelmann

Dieter A. Enkelmann

Director/Board Member at COSMO PHARMACEUTICALS N.V.

64 year
Finance
Health Technology
Consumer Non-Durables

Profile

Mr. Dieter A. Enkelmann is a Chief Financial Officer at Bank Julius Bär & Co. AG, at Julius Bär Gruppe AG, an Independent Non-Executive Director at Cosmo Pharmaceuticals NV, and a Chairman-Foundation Board at Stiftung Für Angewandte Krebsforschung. He is on the Board of Directors at Cosmo Pharmaceuticals NV. From 2003 until 2006 he was the Chief Financial Officer of Barry Callebaut AG, the world's leading manufacturer of high-quality cocoa, chocolate and confectionery products which is listed on the SWX. From 1997 to 2003 he was at Swiss Re as Head of Finance of the Business Unit Financial Services and as Head of Corporate Finance and Investor Relations, Treasury. From 1985 to 1997 he was at Credit Suisse First Boston. Mr. Enkelmann holds a law diploma from the University of Zürich.

Dieter A. Enkelmann active positions

CompaniesPositionStart
COSMO PHARMACEUTICALS N.V. Director/Board Member 2005-12-31
Director of Finance/CFO 2009-09-30
Stiftung Für Angewandte Krebsforschung Chairman 2013-12-31
Chairman -
All active positions of Dieter A. Enkelmann

Former positions of Dieter A. Enkelmann

CompaniesPositionEnd
Director of Finance/CFO 2022-06-30
JULIUS BÄR GRUPPE AG Director of Finance/CFO 2022-06-30
Director/Board Member 2015-04-30
GAM HOLDING AG Director/Board Member 2015-04-29
Julius Baer Holding AG Director of Finance/CFO 2007-12-31
See the detail of Dieter A. Enkelmann's experience

Training of Dieter A. Enkelmann

University of Zurich Graduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Dieter A. Enkelmann's experience

Connections

100 +

1st degree connections

13

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies5
GAM HOLDING AG

Finance

BARRY CALLEBAUT AG

Consumer Non-Durables

JULIUS BÄR GRUPPE AG

Finance

SWISS RE LTD

Finance

COSMO PHARMACEUTICALS N.V.

Health Technology

Private companies7

Health Technology

Finance

Health Technology

Julius Baer Holding AG

Finance

Stiftung Für Angewandte Krebsforschung

Finance

Finance

See company connections
  1. Stock Market
  2. Insiders
  3. Dieter A. Enkelmann